Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes.
Abbas Abbasi-GhahramanlooMojtaba Soltani-KermanshahiKamyar MansoriMaryam Khazaei-PoolMasoudreza SohrabiHamid Reza BaradaranZahra TaleblooAli GholamiPublished in: International journal of general medicine (2020)
Our study suggests that SF-36 and WHOQoL-BREF are reliable instruments for clinical and research uses, respectably. However, results of the goodness of fit showed that the WHOQoL-BREF was fitted well. Also, the WHOQoL-BREF can be considered more suitable for the study population.
Keyphrases